SkinHealth Systems Financials - Benzinga

SkinHealth Systems Inc

SKINNASDAQ

Trade with Public

Trade with Public

$0.6900

-0.0471-6.39%

At close: Sep 9, 5:00 PM EST

$0.6869

-0.0031-0.45%

After Hours: 6:31 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

SkinHealth Systems Financials

SkinHealth Systems (SKIN) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Beauty Health Sees Q3 Sales $65.000M-$70.000M vs $69.220M Est

Beauty Health (NASDAQ:SKIN) sees Q3 sales of $65.000 million-$70.000 million vs $69.220 million analyst estimate.

Benzinga Newsdesk

PRO
Beauty Health Narrows FY2026 Sales Guidance from $280.000M-$295.000M to $280.000M-$290.000M vs $289.529M Est

Beauty Health (NASDAQ:SKIN) narrows FY2026 sales outlook from $280.000 million-$295.000 million to $280.000 million-$290.000 million vs $289.529 million estimate.

Benzinga Newsdesk

PRO
Beauty Health Q2 EPS $(0.02), Inline, Sales $72.100M Miss $74.294M Estimate

Beauty Health (NASDAQ:SKIN) reported quarterly losses of $(0.02) per share which met the analyst consensus estimate. This is a 166.67 percent decrease over earnings of $0.03 per share from the same period last year.

Benzinga Newsdesk

PRO
Beauty Health Sees Q2 Sales $72.000M-$77.000M vs $76.764M Est

Beauty Health (NASDAQ:SKIN) sees Q2 sales of $72.000 million-$77.000 million vs $76.764 million analyst estimate.

Benzinga Newsdesk

PRO
Beauty Health Lowers FY2026 Sales Guidance from $285.000M-$305.000M to $280.000M-$295.000M vs $297.498M Est

Beauty Health (NASDAQ:SKIN) lowers FY2026 sales outlook from $285.000 million-$305.000 million to $280.000 million-$295.000 million vs $297.498 million estimate.

Benzinga Newsdesk

PRO
Beauty Health Q1 EPS $(0.05) Beats $(0.07) Estimate, Sales $64.900M Miss $66.448M Estimate

Beauty Health (NASDAQ:SKIN) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.07) by 28.57 percent. This is a 37.5 percent increase over losses of $(0.08) per share from the

Benzinga Newsdesk